In conclusion, the present study confirmed that eIF3a acts as an oncogene in CRC, as silencing it effectively inhibited various malignant behaviors, with PI3K/AKT signaling likely playing a key role in mediating the effects of eIF3a as an oncogene. The gene discussed is EIF3A; the disease is colorectal carcinoma.